News for ResMed Inc. (RSMDF)

On June 4, 2025, Peter Farrell, Director of ResMed Inc (RMD), sold 2,000 shares of the company, according to a SEC Filing. Following this transaction, the insid

On June 2, 2025, Brett Sandercock, the Chief Financial Officer of ResMed Inc's subsidiary, sold 1,000 shares of ResMed Inc (RMD). Following this transaction, th

You may be concerned about the recent declines in AI stocks such as NVDA.

On May 20, 2025, Witte De, a Director at ResMed Inc (RMD), sold 2,000 shares of the company, as reported in a SEC Filing. Following this transaction, the inside

Below is the April 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG). Liberty All-Star Growth Fund, Inc. Ticker: ASG Monthly Update,

Resmed (RMD) has been designated as the Official Sleep Partner for the Qatar Airways British & Irish Lions Tour to Australia. In this role, Resmed will initiate

On May 7, 2025, Peter Farrell, Director at ResMed Inc (RMD), sold 2,000 shares of the company, according to a SEC Filing. Following this transaction, the inside

ResMed's acquisition of VirtuOx is set to advance its diagnostic capabilities. Analysts predict a potential 9.62% upside for ResMed stock. ResMed is

Resmed (RMD) has made a strategic move by acquiring VirtuOx, a prominent independent diagnostic testing facility. This acquisition underscores Resmed's dedicati

ResMed Inc (RMD) showcases robust revenue growth and improved gross margins in recent quarters.Investments in innovation and digital health solutions position

Shares of ResMed Inc (RMD) surged 11.28% in mid-day trading on Apr 24. The stock reached an intraday high of $239.00, before settling at $238.64, up from it

ResMed Inc (RMD) has recently been in the spotlight, drawing interest from investors and financial analysts due to its robust financial stance. With shares curr

U.S. stocks were higher, with the Nasdaq Composite gaining around 300 points on Thursday. Shares of Texas Instruments Incorporated TXN rose sharply during Thur...

Revenue: $1.29 billion, an 8% increase year-over-year, 9% in constant currency terms.Gross Margin: Increased by 140 basis points to 59.9%.Net Income: Increased

The ASX200 was trading higher on Thursday afternoon, bolstered by strong performances among mining companies

Summary ResMed Inc (RMD) announced its financial results for the third quarter of fiscal year 2025, ending March 31, 2025. The company reported an 8% increase i

Mizuho analyst Anthony Petrone has revised the price target for ResMed (RMD), lowering it from $280 to $265 while maintaining an Outperform rating. This adjustm

Citi has introduced a "downside 90-day catalyst watch" on ResMed Inc. (RMD), despite maintaining a Buy rating and setting a price target of A$44. The move comes

We came across a bullish thesis on ResMed Inc. (RMD) on Substack by LongTermValue Research. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc. (RMD)’s share was trading at $223 as of April 2nd. RMD’s trailing and forward P/E were 26.33 and 21.79 respectively according to Yahoo Finance. ResMed (RMD), a $32.5 billion […]